http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105793235-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5178a7cddf9a77106a64b3a9c1e04ab7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-24
filingDate 2014-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16404ef11cd1a3d6bb25dd4f1d7be3df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b9cba36e00b6412e32b5a781bb65d0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59d1b618ad709e093666c76525f8d015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c21e5986762208cb0119844e84999ece
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_def94d8e3e053aaf3e706b665557312c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9a1b5a1d1dae1d2129cb156a117ede1
publicationDate 2016-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105793235-A
titleOfInvention Alternative methods for purifying intermediates in the synthesis of nonionic X-ray contrast agents
abstract The present invention describes an alternative continuous downstream process for the preparation of 5?acetamido?N,N'?bis(2,3?dihydroxypropyl)?2,4,6?triiodoisophthalamide ("Compound A") method. Compound A is a key intermediate in the preparation of iodixanol and iohexol, two of the most important commercially available non-ionic x-ray contrast agents.
priorityDate 2013-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2277859-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012051850-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2277851-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4250113-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007073202-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101687051-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5811581-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003236407-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432398749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393644
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414870011
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491824
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426158753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591821
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6956
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11115326
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411302445
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID140358977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419765613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73561
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24188569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154325288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447803057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419573795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10395011
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424885426
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485992

Total number of triples: 56.